This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Abstract
The cancer target glutaminase (GLS) has proven to be a fascinating protein. Since it was first described to be regulated by the oncogene Myc 10 years ago, several other transcriptional, posttranscriptional, and posttranslational regulatory mechanisms have emerged, and the list is growing. A recent study by Deng and colleagues revealed that an antisense (AS) long noncoding RNA named GLS-AS, which is negatively regulated by Myc, downregulates GLS in pancreatic cancer. The Myc/GLS-AS/GLS regulatory axis is activated by nutrient stress, which is important for the often hypovascular pancreatic cancer, displaying the significance of GLS for the progression of this highly lethal type of cancer.
See related article by Deng et al., p. 1398
- Received January 24, 2019.
- Accepted January 25, 2019.
- Published first April 1, 2019.
- ©2019 American Association for Cancer Research.
Log in using your username and password
Purchase access
Volume 79, Issue 7
